Dedicated to new beginnings
Every patient deserves the best possible start after surgery.
The Risk Assessment Tool is described in the publication “The Simplified Surgical Site Event Risk Assessment (SSERA) Model” which was published in Wounds International in 2023.
The background research and development of the risk assessment tool described in this publication were conducted by the SSERA Group, chaired by R. Morgan-Jones, Consultant Orthopaedic Surgon. The SSERA Group consists of 9 consultants paid by Molnlycke Health Care AB. Although a Molnlycke employee was involved in the background research, Molnlycke has not controlled (or regulated) the research carried out by the members of the SSERA Group
Download the publication here: ”The simplified surgical site event risk assessment (SSERA) model“
- While the identification of the obvious high risk patient may not require the use of an assessment tool, risk assessment tools will aid in identifying patients not so obviously at increased risk of SSC who may benefit from the application of advanced therapies such as ciNPT
- To secure against habituated use of advanced therapies such ciNPT where there is unlikely to be clinical benefit
Studies indexed in PubMed were identified through the following search terms:
- Surgical site infection
- Risk factors
- Surgical risk factors
- Surgical site risk assessment.
A total of 1,059 abstracts were found, from which 20 validated surgical site risk assessment tools were identified. It is through an assessment of these tools that we developed the risk assessment tool.
For clarity and ease of use, we classify risk as being either:
- Intrinsic (patient-related)
- Extrinsic (procedure-related)
Get in touch to discuss how we can equip your team with the tools, training and products needed to manage closed surgical incisions.